Home › Companies › GeneDx Holdings Corp. › 2025-2026

GeneDx Holdings Corp. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and GeneDx Holdings Corp.’s Form 8-K, filed 2026-06-23 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 7Reported items
  • 326Asset managers
  • 1,742Fund votes
  • 2026-06-18Meeting date

Proxy season: 2025-2026

Explore GeneDx Holdings Corp. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by GeneDx Holdings Corp.

These tallies are GeneDx Holdings Corp.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-23 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

GeneDx Holdings Corp. — official shareholder meeting results, meeting held 2026-06-18
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Katherine Stueland 18,325,894---- 5,893,4663,409,327 Majority: yes
Proposal 2: The Auditor Ratification Proposal — To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026: 27,466,639158,8843,164 ---- Majority: yes
Proposal 3: The Advisory Vote on Executive Compensation of Named Executive Officers Proposal — To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement: 22,705,9461,471,59341,821 ---- Majority: yes

Source: GeneDx Holdings Corp., Form 8-K, filed with the SEC on 2026-06-23 — read the filing on EDGAR.

How asset managers voted at the GeneDx Holdings Corp. 2025-2026 meeting

Each item below shows how the 326 asset managers that disclosed a GeneDx Holdings Corp. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of GeneDx Holdings Corp.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, on a non-binding advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 22,705,946AGAINST: 1,471,593

GeneDx Holdings Corp.’s own tally for this item (“Proposal 3: The Advisory Vote on Executive Compensation of Named Executive Officers Proposal — To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's d”): 22,705,946 for, 1,471,593 against, per its Form 8-K filed 2026-06-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 29,666,318 outstanding shares: 77% for, 5% against (81% of the company cast a for/against vote).

The 323 asset managers below cast 93% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 93%7%
FOR: 92.9%AGAINST: 7.1%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “Approval, on a non-binding advisory basis, the compensation of our named executive officers.” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Casdin Capital, LLC3,007,1640 00For
Corvex Management LP2,912,5700 00For
ARK ETF Trust1,227,6630 00For
Vanguard1,195,4953 00For
BlackRock1,147,1580 00For
Invesco967,8990 00For
WESTFIELD CAPITAL MANAGEMENT CO LP964,7040 00For
Fidelity903,4980 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC656,7920 00For
Amova Asset Management Co., Ltd.629,6400 00For
Putnam584,3910 00For
Capital Group0554,191 00Against
GEODE CAPITAL MANAGEMENT, LLC507,2670 00For
Newton Investment Management North America, LLC0478,196 00Against
MUTUAL FUND SERIES TRUST478,1230 00For
Aberdeen371,3580 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/365,0040 00For
MFS352,6880 00For
Charles Schwab344,6530 00For
BNY Mellon20,538294,248 00Against
Wellington298,9710 00For
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC294,1670 00For
Citadel293,1410 00For
State Street284,1220 00For
RA CAPITAL MANAGEMENT, L.P.277,5980 00For

Showing the 25 largest of 323 asset managers. See all 323 in the interactive database.

2. Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

ONE YEAR 65%1 YEAR 32%

The 312 asset managers below cast 100% of the shares they voted on this item FOR (252,921 for, 0 against).

FOR: 252,921 (1.0%)ABSTAIN: 1,153 (0.0%)ONE YEAR: 17,295,037 (65.1%)1 YEAR: 8,490,429 (31.9%)1YR: 335,461 (1.3%)THREE YEARS: 120,948 (0.5%)3 YEARS: 51,363 (0.2%)1-YEAR: 29,271 (0.1%)NOT VOTED: 73 (0.0%)1.0: 48 (0.0%)3.0: 1 (0.0%)
Largest asset managers voting on “Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Casdin Capital, LLC00 00One Year
Corvex Management LP00 001 Year
ARK ETF Trust00 001 Year
Vanguard00 00One Year
BlackRock00 001 Year
Invesco00 00One Year
WESTFIELD CAPITAL MANAGEMENT CO LP00 00One Year
Fidelity00 00One Year
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC00 00One Year
Amova Asset Management Co., Ltd.00 00One Year
Putnam00 00One Year
Capital Group00 00One Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
Newton Investment Management North America, LLC00 00One Year
MUTUAL FUND SERIES TRUST00 00One Year
Aberdeen00 00One Year
MASSACHUSETTS FINANCIAL SERVICES CO /MA/00 00One Year
MFS00 00One Year
Charles Schwab00 001 Year
BNY Mellon00 00One Year
Wellington00 001 Year
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC00 001 Year
Citadel00 00One Year
State Street00 00One Year
RA CAPITAL MANAGEMENT, L.P.00 00One Year

Showing the 25 largest of 312 asset managers. See all 312 in the interactive database.

3. RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 27,466,639AGAINST: 158,884

GeneDx Holdings Corp.’s own tally for this item (“Proposal 2: The Auditor Ratification Proposal — To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026:”): 27,466,639 for, 158,884 against, per its Form 8-K filed 2026-06-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 29,666,318 outstanding shares: 93% for, 0.6% against (93% of the company cast a for/against vote).

The 103 asset managers below cast 99.8% of the shares they voted on this item FOR (8,840,713 for, 12,370 against).

FOR 99.8%
FOR: 8,840,713 (99.8%)AGAINST: 12,370 (0.1%)ABSTAIN: 914 (0.0%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust1,227,6630 00For
Vanguard1,024,0010 00For
Fidelity708,3390 00For
BlackRock502,4090 00For
MUTUAL FUND SERIES TRUST478,1230 00For
Invesco459,9480 00For
MFS352,6880 00For
Capital Group335,4610 00For
BNY Mellon292,7800 00For
OBERWEIS FUNDS247,3000 00For
Putnam229,0240 00For
HARBOR FUNDS222,2430 00For
FRANKLIN STRATEGIC SERIES201,6660 00For
Columbia Threadneedle179,8470 00For
Waddell & Reed173,4050 00For
Charles Schwab172,3220 00For
Royce162,4250 00For
WILLIAM BLAIR FUNDS156,6620 00For
ALGER FUNDS144,8400 00For
Hartford139,8160 00For
Thrivent104,6750 00For
Aberdeen92,8160 00For
Dimensional87,5580 00For
CARILLON SERIES TRUST65,0670 00For
Principal Exchange-Traded Funds63,5200 00For

Showing the 25 largest of 103 asset managers. See all 103 in the interactive database.

4. Election of Director: Katherine Stueland

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

76% Majority: yes · of votes cast

FOR 76%WITHHELD 24%
FOR: 18,325,894WITHHELD: 5,893,466

GeneDx Holdings Corp.’s own tally for this item (“Elect Director: Katherine Stueland”): 18,325,894 for, 5,893,466 withheld, per its Form 8-K filed 2026-06-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 29,666,318 outstanding shares: 62% for, 20% withheld (82% of the company cast a for/withheld vote).

The 101 asset managers below cast 100% of the shares they voted on this item FOR (6,293,672 for, 0 against).

FOR 71%ABSTAIN 29%
FOR: 6,293,672 (71.2%)ABSTAIN: 2,549,623 (28.8%)
Largest asset managers voting on “Election of Director: Katherine Stueland” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust1,227,6630 00For
Vanguard1,023,9880 130For
Fidelity632,8140 75,5250For
BlackRock502,4090 00For
MUTUAL FUND SERIES TRUST00 478,1230Abstain
Invesco459,9480 00For
MFS00 352,6880Abstain
Capital Group335,4610 00For
BNY Mellon292,0590 7210For
OBERWEIS FUNDS00 247,3000Abstain
Putnam229,0240 00For
HARBOR FUNDS00 222,2430Abstain
FRANKLIN STRATEGIC SERIES201,6660 00For
Columbia Threadneedle179,8470 00For
Waddell & Reed00 173,4050Abstain
Charles Schwab172,3220 00For
Royce162,4250 00For
WILLIAM BLAIR FUNDS00 156,6620Abstain
ALGER FUNDS00 144,8400Abstain
Hartford139,8160 00For
Thrivent00 104,6750Abstain
Aberdeen92,8160 00For
Dimensional00 87,5580Abstain
CARILLON SERIES TRUST00 65,0670Abstain
Principal Exchange-Traded Funds00 63,5200Abstain

Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.

5. 14A Executive Compensation Vote Frequency

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

1 YEAR 99.9%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1 YEAR: 11,501 (100.0%)3 YEARS: 1 (0.0%)
Largest asset managers voting on “14A Executive Compensation Vote Frequency” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
NORTHERN LIGHTS FUND TRUST II00 001 Year
LEAVELL INVESTMENT MANAGEMENT, INC.00 001 Year
Williamson Legacy Group, LLC00 003 Years
MQS Management LLC00 00--

6. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

1 YEAR 97%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1 YEAR: 43,262 (96.6%)ONE YEAR: 1,517 (3.4%)
Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Granahan Investment Management, LLC00 001 Year
APG Asset Management US Inc.00 00One Year
CIDEL ASSET MANAGEMENT INC00 00One Year

7. Election of Directors

DIRECTOR ELECTIONS

All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR.

FOR: 100.0%
Largest asset managers voting on “Election of Directors” at GeneDx Holdings Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
NORTHERN LIGHTS FUND TRUST II10,7010 00For
Williamson Legacy Group, LLC10 00For

Largest GeneDx Holdings Corp. shareholders voting in 2025-2026

Ranked by the number of GeneDx Holdings Corp. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 29,666,318 shares outstanding at the time of that meeting.

Top GeneDx Holdings Corp. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Casdin Capital, LLC 10.14%
2Corvex Management LP 9.82%
3ARK ETF Trust 4.14%
4Vanguard 4.03%
5BlackRock 3.87%
6Invesco 3.26%
7WESTFIELD CAPITAL MANAGEMENT CO LP 3.25%
8Fidelity 3.05%
9WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.21%
10Amova Asset Management Co., Ltd. 2.12%

Reported GeneDx Holdings Corp. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

GeneDx Holdings Corp. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Keith A. Meister 18.06% 13D
Meister, Keith A. 18.06% 13D
BlackRock 5.23% 13F
Goldman Sachs 4.50% 13F
Vanguard Group 4.01% 13F
Citadel Advisors 2.59% 13F
Franklin Templeton 2.05% 13F
Geode Capital 1.85% 13F
Invesco 1.82% 13F
Morgan Stanley 1.71% 13F

Percentages above are of 29,666,318 shares outstanding, as reported by GeneDx Holdings Corp. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from GeneDx Holdings Corp.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At GeneDx Holdings Corp.'s shareholder meeting held 2026-06-18, in the 2025-2026 proxy season, 326 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,742 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on a non-binding advisory basis, the compensation of our named executive officers. — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: GeneDx Holdings Corp.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-23.

GeneDx Holdings Corp. proxy season coverage: 2025-2026 (this page).